萬達電影(002739.SZ):萬達投資擬向莘縣融智轉讓8.14%股份
格隆匯7月17日丨萬達電影(002739.SZ)公佈,2023年7月17日,公司控股股東萬達投資與其一致行動人莘縣融智簽署了《關於萬達電影股份有限公司之股份轉讓協議》(稱“《股份轉讓協議》”),萬達投資擬向莘縣融智轉讓其持有的萬達電影無限售條件流通股1.77億股(佔公司總股本的8.14%),轉讓價格為13.17元/股(該交易價格約為《股份轉讓協議》簽署日前一個交易日標的股票收盤價的90%),轉讓價格為23.36億元。
本次權益變動不會導致公司控股股東、實際控制人發生變化,公司控股股東仍為萬達投資,實際控制人仍為王健林先生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.